NO147448C - Analogifremgangsmaate til fremstilling av terapeutisk aktive 2,4-diklorfenyl-imidazolyl-etanoner(oler) - Google Patents

Analogifremgangsmaate til fremstilling av terapeutisk aktive 2,4-diklorfenyl-imidazolyl-etanoner(oler)

Info

Publication number
NO147448C
NO147448C NO780315A NO780315A NO147448C NO 147448 C NO147448 C NO 147448C NO 780315 A NO780315 A NO 780315A NO 780315 A NO780315 A NO 780315A NO 147448 C NO147448 C NO 147448C
Authority
NO
Norway
Prior art keywords
ethanones
dichlorphenyl
oles
imidazolyl
preparation
Prior art date
Application number
NO780315A
Other languages
English (en)
Norwegian (no)
Other versions
NO147448B (no
NO780315L (no
Inventor
Wolfgang Kraemer
Karl Heinz Buechel
Manfred Plempel
Original Assignee
Bayer Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Ag filed Critical Bayer Ag
Publication of NO780315L publication Critical patent/NO780315L/no
Publication of NO147448B publication Critical patent/NO147448B/no
Publication of NO147448C publication Critical patent/NO147448C/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
NO780315A 1977-02-11 1978-01-27 Analogifremgangsmaate til fremstilling av terapeutisk aktive 2,4-diklorfenyl-imidazolyl-etanoner(oler) NO147448C (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19772705677 DE2705677A1 (de) 1977-02-11 1977-02-11 2,4-dichlorphenyl-imidazolyl-aethanone(ole), verfahren zu ihrer herstellung sowie ihre verwendung als arzneimittel

Publications (3)

Publication Number Publication Date
NO780315L NO780315L (no) 1978-08-14
NO147448B NO147448B (no) 1983-01-03
NO147448C true NO147448C (no) 1983-04-13

Family

ID=6000864

Family Applications (1)

Application Number Title Priority Date Filing Date
NO780315A NO147448C (no) 1977-02-11 1978-01-27 Analogifremgangsmaate til fremstilling av terapeutisk aktive 2,4-diklorfenyl-imidazolyl-etanoner(oler)

Country Status (17)

Country Link
JP (1) JPS53101375A (de)
AT (1) AT361910B (de)
AU (1) AU516580B2 (de)
BE (1) BE863851A (de)
CA (1) CA1097356A (de)
CH (1) CH634058A5 (de)
DE (1) DE2705677A1 (de)
DK (1) DK61378A (de)
ES (1) ES466867A1 (de)
FI (1) FI66851C (de)
FR (1) FR2380263A1 (de)
GB (1) GB1554841A (de)
IL (1) IL54001A (de)
IT (1) IT1093702B (de)
NL (1) NL177214C (de)
NO (1) NO147448C (de)
SE (1) SE442401B (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2713777C3 (de) * 1977-03-29 1979-10-31 Bayer Ag, 5090 Leverkusen Verfahren zur Herstellung von l-Azolyl-33-dimethyl-l-phenoxy-butan-2-onen
AT394800B (de) * 1979-09-06 1992-06-25 Bristol Myers Squibb Co Mittel zur wachstumshemmung von pilzen und bakterien
AT382147B (de) * 1979-09-06 1987-01-12 Bristol Myers Co Verfahren zur herstellung von neuen 1-phenaethylimidazol-derivaten
EP0049060A1 (de) * 1980-09-13 1982-04-07 Beecham Group Plc Imidazole

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2105490C3 (de) * 1971-02-05 1979-06-13 Bayer Ag, 5090 Leverkusen 1 -Imidazolylketonderivate

Also Published As

Publication number Publication date
IL54001A0 (en) 1978-04-30
FI66851B (fi) 1984-08-31
CH634058A5 (en) 1983-01-14
BE863851A (fr) 1978-08-10
IT1093702B (it) 1985-07-26
IT7820129A0 (it) 1978-02-09
FI780431A (fi) 1978-08-12
NL177214C (nl) 1985-08-16
GB1554841A (en) 1979-10-31
ES466867A1 (es) 1978-10-01
DE2705677A1 (de) 1978-08-17
FI66851C (fi) 1984-12-10
SE7801526L (sv) 1978-08-12
AU516580B2 (en) 1981-06-11
ATA94378A (de) 1980-09-15
AT361910B (de) 1981-04-10
NL7801579A (nl) 1978-08-15
NL177214B (nl) 1985-03-18
NO147448B (no) 1983-01-03
SE442401B (sv) 1985-12-23
CA1097356A (en) 1981-03-10
DK61378A (da) 1978-08-12
FR2380263A1 (fr) 1978-09-08
JPS53101375A (en) 1978-09-04
AU3324378A (en) 1979-08-23
IL54001A (en) 1981-09-13
FR2380263B1 (de) 1982-11-19
NO780315L (no) 1978-08-14

Similar Documents

Publication Publication Date Title
NO792787L (no) Fremgangsmaate ved fremstilling av antiinflammatorisk aktive 4,5-diaryl-2-nitroimidazoler
NO149662C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive c-076-forbindelser
NO803851L (no) Fremgangsmaate til fremstilling av 4,1`,6`-triklor-4,1`,6`-trideoksy-galaktosukrose
NO157817C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive glycinamidderivater.
NO158540C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive 2-penem-forbindelser.
NO166320C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive tetrazolderivater.
NO156787C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive kinolonderivater.
NO148959C (no) Fremgangsmaate ved fremstilling av tumor-motvirkende antracyklinglykosidantibiotika, betegnet ma 144
NO156694C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive 10-(1,2-propadienyl)-steroider.
NO151322C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 2(5-metyl-4-imidazolyl-metyltio)etylamino-(no2-heterocyklisk gruppe) forbindelser
NO157538C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive benzothiazolsufonamidderivater.
NO801626L (no) Fremgangsmaate ved fremstilling av usymmetriske 1,3-disubstituerte nitrosourea-forbindelser
NO147448C (no) Analogifremgangsmaate til fremstilling av terapeutisk aktive 2,4-diklorfenyl-imidazolyl-etanoner(oler)
NO150158C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive 6,7-dimetoksyquinazolinderivater
NO781489L (no) Fremgangsmaate til fremstilling av 1,2-dikloretan
NO791458L (no) Fremgangsmaate til fremstilling av 1,2-dikloretan
NO154795C (no) Analogifremgangsmaate ved fremstilling av terapeutisk virksomme 1,2,4-oxadiazolin-5-on-derivater.
NO146777C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 6h-indolo (3,2,1-de)-(1,5)-naftyridinderivater
NO147341C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive 2,9-dioxatricyclo-(4.3.1.03,7)-decaner
DK178978A (da) Fremgangsmaade til fremstilling af 3,5-disubstituerede 1h-1,2,4-triazolderivater
NO154494C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive fluorprostacykliner.
NO155054C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive 3-amino-1-benzoxepin-5(2h)-derivater.
NO154088C (no) Analogifremgangsmaate til fremstilling av terapeutisk aktive tetrahydrokinoliner.
NO791572L (no) Fremgangsmaate for fremstilling av 1,5-dimetyl-bicyklo(3,2,1)oktanol-8
NO158063C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive pyrazolo-pyrido-diazepin-derivater.